Chris Norbury
Group leader · Oxford Biochemistry + Pathology (research group seed) · University of Oxford
Quick answer: Chris Norbury is Group leader at University of Oxford. Chris Norbury shows an active PhD hiring signal as of 2026-09-11.
⭐ Chris will retire at the end of the 2026-27 academic year and is not in a position to accept applications from prospective graduate students or postdocs.
Research interests
Cell cycle regulation, cyclin-dependent protein kinases (CDKs) in cancer cells, cell cycle checkpoints, drug resistance, gene expression at post-transcriptional levels, mRNA uridylation, ZCCHC11 (TUT4), DIS3L2, CDK1, transcriptional re-programming during tumorigenesis
Selected publications (since 2023)
[2023] Cyclin-dependent kinases: masters of the eukaryotic universe. Pluta, A., Studniarek, C., Murphy, S. and Norbury, C.J. WIREs RNA – (in press)
[2023] Koller and the dawn of cancer cytogenetics. Norbury, C.J. British Journal of Cancer – 128: 402-403.
Frequently asked questions
Is Chris Norbury hiring PhD students at University of Oxford?
Yes. As of 2026-09-11, Chris Norbury's faculty page shows a PhD hiring signal: Chris will retire at the end of the 2026-27 academic year and is not in a position to accept applications from prospective graduate students or postdocs..
What does Chris Norbury research?
Cell cycle regulation, cyclin-dependent protein kinases (CDKs) in cancer cells, cell cycle checkpoints, drug resistance, gene expression at post-transcriptional levels, mRNA uridylation, ZCCHC11 (TUT4), DIS3L2, CDK1, transcriptional re-programming during tumorigenesis
Data last updated: 2026-09-11 · Source: phd-match.com faculty database.
Is Chris Norbury a match for your research?
Upload your CV and get matched to professors who fit — with hiring signals.
Start matching